Call for proposals to support the development of novel antivirals (HERA) - CP-g-24-105

Last updated: 18.7.2025
Grant

The Call for proposals to support the development of novel antivirals (HERA) is a key initiative under the EU4Health Programme, aiming to bolster the European Union's preparedness against serious cross-border health threats. This program specifically targets the advancement of broad-spectrum antivirals, contributing to the creation of a robust portfolio of medical countermeasures and reducing strategic dependencies in health innovation.

Who is Funded

This section details the target groups and overarching objectives of the funding program, which aims to strengthen the European Union's health security. Funding is available for a wide range of legal entities across EU Member States and associated countries, all contributing to the development of novel antiviral therapeutics.

What is Funded

This section outlines the specific types of projects and thematic areas eligible for funding, focusing on the critical development of new antiviral therapeutics.

Type and Scope of Funding

This section provides essential details about the financial support available under this program, including the type of financial instrument and the total allocated budget.

Conditions and Requirements

This section details the key conditions and requirements for applicants, covering aspects from application terms to collaboration and legal provisions.

Application Procedure

This section outlines the step-by-step process for submitting applications and explains how proposals are evaluated and decisions are made.

This section identifies the foundational legal instruments and regulatory frameworks that underpin the funding program, ensuring its legitimacy and guiding its implementation.

Similar Programs

#novel antivirals#HERA funding#EU4Health Programme#antiviral development#health crisis preparedness#EU grants#medical countermeasures#broad-spectrum antivirals#viral therapeutics#public health#infectious diseases#drug development#clinical trials#health systems#EU research funding#EU4H-2024-PJ-01-4#health innovation#regulatory pathway#biomedical research

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

10,000,000 €

Allocated Budget

Allocated Budget:

10,000,000 €

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union Member States and associated countries

Sectors

Sectors:

Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development

Beneficiaries

Beneficiaries:

Public Health, Healthcare, Research & Development

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Applied Research, Experimental Development, Pilot Testing, Product Development, Commercialization

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

European Health and Digital Executive Agency (HaDEA)

Additional Partners:

BCN HEALTH ECONOMICS & OUTCOMES RESEARCH SL (Spain), PLUMESTARS SRL (Italy), MEDIZINISCHE UNIVERSITAET WIEN (Austria), GLANTREO LIMITED (Ireland), CENTRE FOR SUSTAINABLE SOLUTIONS IRELAND COMPANY LIMITED BY GUARANTEE (Ireland), Paras Biopharmaceuticals Finland Oy (Finland), ALLWEB SOLUTIONS - INFORMATION SYSTEMS SOCIETE ANONYME (Greece), DevsHealth SL (Spain), GRANT GARANT SRO (Czechia), Papanikolaou Hospital (Greece), GOLEM - GESELLSCHAFT FUR INTEGRIERTE MIKROELEKTRONISCHE KOMPLETTLOESUNGEN GMBH (Austria), ASSOCIATION FOR SUSTAINABLE INNOVATIVE DEVELOPMENTS IN ECONOMICS ENVIRONMENT AND SOCIETY (Austria), IMC- INDUSTRIAL MANAGEMENT CONSULTING SLOVAKIA, S.R.O. (Slovakia), FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA (Spain), RISE RESEARCH INSTITUTES OF SWEDEN AB (Sweden), CENTRO INTERNAZIONALE PER LA PROMOZIONE DELL'EDUCAZIONE E LO SVILUPPO ASSOCIAZIONE (Italy), Flow Analysis and Simulation Team (Greece), Lorella BARON (University of Udine) (Italy), INSILICOTRIALS TECHNOLOGIES S.P.A. (Italy), LIONEX GMBH (Germany), UNIVERSITY OF GALWAY (Ireland), Paulina VILLALOBOS QUESADA (MINDS & SPARKS) (Austria), SYNYO GmbH (Austria), BUKOVINIAN STATE MEDICAL UNIVERSITY (Ukraine), C4G - CONSULTING AND TRAINING NETWORK, LDA (Portugal), MINDS & SPARKS GMBH (Austria), Municipal uncommercial enterprise Ivano-Frankivsk Regional Perinatal Center of Ivano-Frankivsk Regional Council (Ukraine), INTERSPREAD GMBH (Austria), DISSEMINATION.COM (Austria), UNIVERSITE DU LUXEMBOURG (Luxembourg), INSTITOUTO ANAPTIXIS EPICHEIRIMATIKOTITAS ASTIKI ETAIREIA (Greece), University Multiprofile Hospital for Active Treatment Sveta Marina EAD (Bulgaria)

0 x 0
XS